Ebright RY, Dilly J, Shaw AT, Aguirre AJ. Response and Resistance to RAS Inhibition in Cancer. Cancer discovery. 2025:OF1-OF25. doi:10.1158/2159-8290.CD-25-0349
Publications
Amado P, Dillinger C, Bahou C, et al. Ultrasound-activated cilia for biofilm control in indwelling medical devices. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(18):e2418938122. doi:10.1073/pnas.2418938122
Levesque S, Bauer DE. CRISPR-based therapeutic genome editing for inherited blood disorders. Nature reviews. Drug discovery. 2025. doi:10.1038/s41573-025-01236-y
Chandrasekaran SN, Alix E, Arevalo J, et al. Morphological map of under- and overexpression of genes in human cells. Nature methods. 2025;22(8):1742-1752. doi:10.1038/s41592-025-02753-9
Bizzotto S, Talukdar M, Stronge EA, et al. Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(29):e2509622122. doi:10.1073/pnas.2509622122
Liu J, Tran D, Xue L, et al. Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy. Nature genetics. 2025. doi:10.1038/s41588-025-02250-x
Kany S, Friedman SF, Al-Alusi M, et al. Electrocardiogram-Based Artificial Intelligence to Identify Coronary Artery Disease. JACC. Advances. 2025;4(9):102041. doi:10.1016/j.jacadv.2025.102041
LaVerriere E, Johnson ZM, Shieh M, et al. Marked heterogeneity in malaria infection rate in a Malian longitudinal cohort. Nature communications. 2025;16(1):6512. doi:10.1038/s41467-025-61462-1
Vera AO, Truex NL, Sreekanth V, Pentelute BL, Choudhary A, Raines RT. Protective antigen-mediated delivery of an anti-CRISPR protein for precision genome editing. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(32):e2426960122. doi:10.1073/pnas.2426960122
Apfelbaum AA, Morin E, Sturm D, et al. A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas. Nature communications. 2025;16(1):7018. doi:10.1038/s41467-025-61820-z